查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
SMA、SCID新生兒篩檢的全球市場的分析 (2023年)
市場調查報告書
商品編碼
1206268

SMA、SCID新生兒篩檢的全球市場的分析 (2023年)

Global Newborn Screening for SMA and SCID Market Research Report 2023
出版日期: | 出版商: QYResearch | 英文 84 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球SMA、SCID新生兒篩檢的市場規模，2022年達到1億2,921萬美元，預計2029年達2億8,804萬美元，預計在預測期間內 (2023年～2029年)以11.51％的年複合成長率成長。

本報告提供全球SMA、SCID新生兒篩檢的市場相關分析，各類型、各用途、各地區 (各國) 的市場趨勢預測 (2018年～2029年)，主要企業的簡介等相關調查。

目錄

第1章 調查概要

  • 調查範圍
  • 各種類的市場分析
    • 市場規模、成長率:各類型 (2018年、2022年、2029年)
    • 設備
    • 套件
    • 軟體
  • 各用途的市場
    • 市場佔有率:各用途 (2018年、2022年、2029年)
    • SCID (脊髓性肌萎縮症) 篩檢
    • SMA (重病複合免疫力缺乏症) 篩檢
  • 分析對像
  • 分析期間

第2章 全球成長趨勢

  • 全球SMA、SCID新生兒篩檢市場展望 (2018年～2029年)
  • SMA、SCID新生兒篩檢的成長趨勢:各地區
  • SMA、SCID新生兒篩檢的市場動態

第3章 各主要企業的競爭情形

  • SMA、SCID新生兒篩檢的主要企業的收益
  • 市場佔有率:企業的各類型 (第一級，第二級，第三級)
  • 分析對像企業:SMA、SCID新生兒篩檢的各收益的排行榜
  • 全球SMA、SCID新生兒篩檢市場集中度
  • SMA、SCID新生兒篩檢的主要企業:總公司、提供區域
  • SMA、SCID新生兒篩檢的主要企業:產品、解決方案、服務
  • 企業合併、收購 (M&A)，擴張計劃

第4章 SMA、SCID新生兒篩檢:各種類的明細資料

  • 過去的市場規模:各類型 (2018年～2023年)
  • 市場規模的預測:各類型 (2024年～2029年)

第5章 SMA、SCID新生兒篩檢:各用途的明細資料

  • 過去的市場規模:各用途 (2018年～2023年)
  • 市場規模的預測:各用途 (2024年～2029年)

第6章 北美

  • 北美的SMA、SCID新生兒篩檢的市場規模 (2018年～2029年)
  • 北美的SMA、SCID新生兒篩檢的市場成長率:各國 (2018年、2022年、2029年)
  • 北美的SMA、SCID新生兒篩檢的市場規模:各國 (2018年～2023年)
  • 北美的SMA、SCID新生兒篩檢的市場規模:各國 (2024年～2029年)
  • 美國
  • 加拿大

第7章 歐洲

  • 歐洲的SMA、SCID新生兒篩檢的市場規模 (2018年～2029年)
  • 歐洲的SMA、SCID新生兒篩檢的市場成長率:各國 (2018年、2022年、2029年)
  • 歐洲的SMA、SCID新生兒篩檢的市場規模:各國 (2018年～2023年)
  • 歐洲的SMA、SCID新生兒篩檢的市場規模:各國 (2024年～2029年)
  • 德國
  • 法國
  • 西班牙
  • 瑞典
  • 挪威

第8章 其他的國家 (RoW)

  • 其他的國家 (RoW) 的SMA、SCID新生兒篩檢的市場規模 (2018年～2029年)
  • 其他的國家 (RoW) 的SMA、SCID新生兒篩檢的市場成長率:各國 (2018年、2022年、2029年)
  • 其他的國家 (RoW) 的SMA、SCID新生兒篩檢的市場規模:各國 (2018年～2023年)
  • 其他的國家 (RoW) 的SMA、SCID新生兒篩檢的市場規模:各國 (2024年～2029年)
  • 亞洲
  • 中東、非洲

第9章 主要企業的簡介

  • Perkinelmer
  • Thermo Fisher
  • ImmunoIVD
  • Labsystems Diagnostics

第10章 分析師的見解/結論

第11章 附錄

The global Newborn Screening for SMA and SCID market was valued at US$ 129.21 million in 2022 and is anticipated to reach US$ 288.04 million by 2029, witnessing a CAGR of 11.51% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The major global companies of Newborn Screening for SMA and SCID include Perkinelmer, Thermo Fisher, ImmunoIVD, Labsystems Diagnostics, and etc. In 2022, the world's top two vendors accounted for approximately 84% of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Newborn Screening for SMA and SCID, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Screening for SMA and SCID.

The Newborn Screening for SMA and SCID market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Newborn Screening for SMA and SCID market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Newborn Screening for SMA and SCID companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  • Perkinelmer
  • Thermo Fisher
  • ImmunoIVD
  • Labsystems Diagnostics

Segment by Type

  • Instruments
  • Kits
  • Software

Segment by Application

  • SCID Screening
  • SMA Screening

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • Spain
  • France
  • Sweden
  • Norway
  • Other Regions
  • Asia
  • MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Newborn Screening for SMA and SCID companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8: North America, Europe and Other Regions segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 9: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 10: The main points and conclusions of the report.

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Newborn Screening for SMA and SCID Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
    • 1.2.2 Instruments
    • 1.2.3 Kits
    • 1.2.4 Software
  • 1.3 Market by Application
    • 1.3.1 Global Newborn Screening for SMA and SCID Market Growth by Application: 2018 VS 2022 VS 2029
    • 1.3.2 SCID Screening
    • 1.3.3 SMA Screening
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Newborn Screening for SMA and SCID Market Perspective (2018-2029)
  • 2.2 Global Newborn Screening for SMA and SCID Growth Trends by Region
    • 2.2.1 Global Newborn Screening for SMA and SCID Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Newborn Screening for SMA and SCID Historic Market Size by Region (2018-2023)
    • 2.2.3 Newborn Screening for SMA and SCID Forecasted Market Size by Region (2024-2029)
  • 2.3 Newborn Screening for SMA and SCID Market Dynamics
    • 2.3.1 Newborn Screening for SMA and SCID Industry Trends
    • 2.3.2 Newborn Screening for SMA and SCID Market Drivers
    • 2.3.3 Newborn Screening for SMA and SCID Market Challenges and Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Newborn Screening for SMA and SCID Players by Revenue
    • 3.1.1 Global Top Newborn Screening for SMA and SCID Players by Revenue (2021-2022)
    • 3.1.2 Global Newborn Screening for SMA and SCID Revenue Market Share by Players (2021-2022)
  • 3.2 Global Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players Ranking by Newborn Screening for SMA and SCID Revenue
  • 3.4 Global Newborn Screening for SMA and SCID Market Concentration Ratio
    • 3.4.1 Global Newborn Screening for SMA and SCID Market Concentration Ratio (CR3 and HHI)
    • 3.4.2 Global Top 3 Companies by Newborn Screening for SMA and SCID Revenue in 2022
  • 3.5 Global Key Players of Newborn Screening for SMA and SCID Head office and Area Served
  • 3.6 Global Key Players of Newborn Screening for SMA and SCID, Product and Application
  • 3.7 Mergers & Acquisitions, Expansion Plans

4 Newborn Screening for SMA and SCID Breakdown Data by Type

  • 4.1 Global Newborn Screening for SMA and SCID Historic Market Size by Type (2018-2023)
  • 4.2 Global Newborn Screening for SMA and SCID Forecasted Market Size by Type (2024-2029)

5 Newborn Screening for SMA and SCID Breakdown Data by Application

  • 5.1 Global Newborn Screening for SMA and SCID Historic Market Size by Application (2018-2023)
  • 5.2 Global Newborn Screening for SMA and SCID Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Newborn Screening for SMA and SCID Market Size (2018-2029)
  • 6.2 North America Newborn Screening for SMA and SCID Market Growth Rate by Country: 2018 VS 2022 VS 2029
  • 6.3 North America Newborn Screening for SMA and SCID Market Size by Country (2018-2023)
  • 6.4 North America Newborn Screening for SMA and SCID Market Size by Country (2024-2029)
  • 6.5 United States
  • 6.6 Canada

7 Europe

  • 7.1 Europe Newborn Screening for SMA and SCID Market Size (2018-2029)
  • 7.2 Europe Newborn Screening for SMA and SCID Market Growth Rate by Country: 2018 VS 2022 VS 2029
  • 7.3 Europe Newborn Screening for SMA and SCID Market Size by Country (2018-2023)
  • 7.4 Europe Newborn Screening for SMA and SCID Market Size by Country (2024-2029)
  • 7.5 Germany
  • 7.6 France
  • 7.7 Spain
  • 7.8 Sweden
  • 7.9 Norway

8 Other Regions

  • 8.1 Other Regions Newborn Screening for SMA and SCID Market Size (2018-2029)
  • 8.2 Other Regions Newborn Screening for SMA and SCID Market Growth Rate by Country: 2018 VS 2022 VS 2029
  • 8.3 Other Regions Newborn Screening for SMA and SCID Market Size by Country (2018-2023)
  • 8.4 Other Regions Newborn Screening for SMA and SCID Market Size by Country (2024-2029)
  • 8.5 Asia
  • 8.6 MEA

9 Key Players Profiles

  • 9.1 Perkinelmer
    • 9.1.1 Perkinelmer Company Details
    • 9.1.2 Perkinelmer Business Overview
    • 9.1.3 Perkinelmer Newborn Screening for SMA and SCID Introduction
    • 9.1.4 Perkinelmer Revenue in Newborn Screening for SMA and SCID Business (2021-2022)
  • 9.2 Thermo Fisher
    • 9.2.1 Thermo Fisher Company Details
    • 9.2.2 Thermo Fisher Business Overview
    • 9.2.3 Thermo Fisher Newborn Screening for SMA and SCID Introduction
    • 9.2.4 Thermo Fisher Revenue in Newborn Screening for SMA and SCID Business (2021-2022)
  • 9.3 ImmunoIVD
    • 9.3.1 ImmunoIVD Company Details
    • 9.3.2 ImmunoIVD Business Overview
    • 9.3.3 ImmunoIVD Newborn Screening for SMA and SCID Introduction
    • 9.3.4 ImmunoIVD Revenue in Newborn Screening for SMA and SCID Business (2021-2022)
  • 9.4 Labsystems Diagnostics
    • 9.4.1 Labsystems Diagnostics Company Details
    • 9.4.2 Labsystems Diagnostics Business Overview
    • 9.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Introduction
    • 9.4.4 Labsystems Diagnostics Revenue in Newborn Screening for SMA and SCID Business (2021-2022)

10 Analyst's Viewpoints/Conclusions

11 Appendix

  • 11.1 Research Methodology
    • 11.1.1 Methodology/Research Approach
    • 11.1.2 Data Source
  • 11.2 Author Details
  • 11.3 Disclaimer

List of Tables

  • Table 1. Global Newborn Screening for SMA and SCID Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
  • Table 2. Key Players of Instruments
  • Table 3. Key Players of Kits
  • Table 4. Key Players of Software
  • Table 5. Global Newborn Screening for SMA and SCID Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
  • Table 6. Global Newborn Screening for SMA and SCID Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 7. Global Newborn Screening for SMA and SCID Market Size by Region (2018-2023) & (US$ Million)
  • Table 8. Global Newborn Screening for SMA and SCID Market Share by Region (2018-2023)
  • Table 9. Global Newborn Screening for SMA and SCID Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 10. Global Newborn Screening for SMA and SCID Market Share by Region (2024-2029)
  • Table 11. Newborn Screening for SMA and SCID Market Trends
  • Table 12. Newborn Screening for SMA and SCID Market Drivers
  • Table 13. Newborn Screening for SMA and SCID Market Challenges and Restraints
  • Table 14. Global Newborn Screening for SMA and SCID Revenue by Players (2021-2022) & (US$ Million)
  • Table 15. Global Newborn Screening for SMA and SCID Market Share by Players (2021-2022)
  • Table 16. Global Top Newborn Screening for SMA and SCID Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Screening for SMA and SCID as of 2022)
  • Table 17. Ranking of Global Top Newborn Screening for SMA and SCID Companies by Revenue (US$ Million) in 2022
  • Table 18. Global 3 Largest Players Market Share by Newborn Screening for SMA and SCID Revenue (CR3 and HHI) & (2021-2022)
  • Table 19. Global Key Players of Newborn Screening for SMA and SCID, Headquarters and Area Served
  • Table 20. Global Key Players of Newborn Screening for SMA and SCID, Product and Application
  • Table 21. Mergers & Acquisitions, Expansion Plans
  • Table 22. Global Newborn Screening for SMA and SCID Market Size by Type (2018-2023) & (US$ Million)
  • Table 23. Global Newborn Screening for SMA and SCID Revenue Market Share by Type (2018-2023)
  • Table 24. Global Newborn Screening for SMA and SCID Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 25. Global Newborn Screening for SMA and SCID Revenue Market Share by Type (2024-2029)
  • Table 26. Global Newborn Screening for SMA and SCID Market Size by Application (2018-2023) & (US$ Million)
  • Table 27. Global Newborn Screening for SMA and SCID Revenue Market Share by Application (2018-2023)
  • Table 28. Global Newborn Screening for SMA and SCID Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 29. Global Newborn Screening for SMA and SCID Revenue Market Share by Application (2024-2029)
  • Table 30. North America Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 31. North America Newborn Screening for SMA and SCID Market Size by Country (2018-2023) & (US$ Million)
  • Table 32. North America Newborn Screening for SMA and SCID Market Size by Country (2024-2029) & (US$ Million)
  • Table 33. Europe Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 34. Europe Newborn Screening for SMA and SCID Market Size by Country (2018-2023) & (US$ Million)
  • Table 35. Europe Newborn Screening for SMA and SCID Market Size by Country (2024-2029) & (US$ Million)
  • Table 36. Other Regions Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 37. Other Regions Newborn Screening for SMA and SCID Market Size by Country (2018-2023) & (US$ Million)
  • Table 38. Other Regions Newborn Screening for SMA and SCID Market Size by Country (2024-2029) & (US$ Million)
  • Table 39. Perkinelmer Company Details
  • Table 40. Perkinelmer Business Overview
  • Table 41. Perkinelmer Newborn Screening for SMA and SCID Product
  • Table 42. Perkinelmer Revenue in Newborn Screening for SMA and SCID Business (2021-2022) & (US$ Million)
  • Table 43. Thermo Fisher Company Details
  • Table 44. Thermo Fisher Business Overview
  • Table 45. Thermo Fisher Newborn Screening for SMA and SCID Product
  • Table 46. Thermo Fisher Revenue in Newborn Screening for SMA and SCID Business (2021-2022) & (US$ Million)
  • Table 47. ImmunoIVD Company Details
  • Table 48. ImmunoIVD Business Overview
  • Table 49. ImmunoIVD Newborn Screening for SMA and SCID Product
  • Table 50. ImmunoIVD Revenue in Newborn Screening for SMA and SCID Business (2021-2022) & (US$ Million)
  • Table 51. Labsystems Diagnostics Company Details
  • Table 52. Labsystems Diagnostics Business Overview
  • Table 53. Labsystems Diagnostics Newborn Screening for SMA and SCID Product
  • Table 54. Labsystems Diagnostics Revenue in Newborn Screening for SMA and SCID Business (2021-2022) & (US$ Million)
  • Table 55. Research Programs/Design for This Report
  • Table 56. Key Data Information from Secondary Sources
  • Table 57. Key Data Information from Primary Sources
  • Table 58. Authors List of This Report
  • Table 59. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

  • Figure 1. Product Picture of Newborn Screening for SMA and SCID
  • Figure 2. Global Newborn Screening for SMA and SCID Market Size Comparison by Type (2023-2029) & (US$ Million)
  • Figure 3. Global Newborn Screening for SMA and SCID Market Share by Type: 2022
  • Figure 4. Global Newborn Screening for SMA and SCID Market Share by Type: 2029
  • Figure 5. Instruments Features
  • Figure 6. Kits Features
  • Figure 7. Software Features
  • Figure 8. Global Newborn Screening for SMA and SCID Market Size by Application (2023-2029) & (US$ Million)
  • Figure 9. Global Newborn Screening for SMA and SCID Market Share by Application: 2022
  • Figure 10. Global Newborn Screening for SMA and SCID Market Share by Application: 2029
  • Figure 11. SCID Screening Case Studies
  • Figure 12. SMA Screening Case Studies
  • Figure 13. Newborn Screening for SMA and SCID Report Years Considered
  • Figure 14. Global Newborn Screening for SMA and SCID Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 15. Global Newborn Screening for SMA and SCID Market Size, (US$ Million), 2018 VS 2023 VS 2029
  • Figure 16. Global Newborn Screening for SMA and SCID Market Share by Region: 2022
  • Figure 17. Global Newborn Screening for SMA and SCID Market Share by Region: 2029
  • Figure 18. Global Newborn Screening for SMA and SCID Market Share by Players in 2022
  • Figure 19. The Top 3 Players Market Share by Newborn Screening for SMA and SCID Revenue in 2022
  • Figure 20. North America Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 21. North America Newborn Screening for SMA and SCID Market Share by Country (2018-2029)
  • Figure 22. United States Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 23. Canada Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 24. Europe Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 25. Europe Newborn Screening for SMA and SCID Market Share by Country (2018-2029)
  • Figure 26. Germany Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 27. France Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 28. Spain Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 29. Sweden Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 30. Norway Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. Other Regions Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. Other Regions Newborn Screening for SMA and SCID Market Share by Country (2018-2029)
  • Figure 33. Asia Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. MEA Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 35. Perkinelmer Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2021-2022)
  • Figure 36. Thermo Fisher Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2021-2022)
  • Figure 37. ImmunoIVD Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2021-2022)
  • Figure 38. Labsystems Diagnostics Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2021-2022)
  • Figure 39. Bottom-up and Top-down Approaches for This Report
  • Figure 40. Data Triangulation
  • Figure 41. Key Executives Interviewed